Krebs Biochemicals & Industries (BOM:524518) Debt-to-Asset : 1.09 (As of Mar. 2024)

Krebs Biochemicals & Industries Debt-to-Asset Chart

Krebs Biochemicals & Industries Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Debt-to-Asset		Get a 7-Day Free Trial					0.61	0.79	0.99	1.31	1.09

Krebs Biochemicals & Industries Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															1.31	-	1.05	-	1.09

Competitive Comparison of Krebs Biochemicals & Industries's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Krebs Biochemicals & Industries's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Krebs Biochemicals & Industries's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krebs Biochemicals & Industries's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Krebs Biochemicals & Industries's Debt-to-Asset falls into.

Krebs Biochemicals & Industries Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Krebs Biochemicals & Industries's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Krebs Biochemicals & Industries's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krebs Biochemicals & Industries  (BOM:524518) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Krebs Biochemicals & Industries Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Krebs Biochemicals & Industries (BOM:524518) Business Description